Abstract
N. Luban (Washington DC, USA): So for those of you who are from institutions that use Epo, please raise your hands if you are using EPO in your prematures. Interesting, one hand went up.
Moderators: N. Luban and C.Th. Smit Sibinga
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
A. Grimm C, Wenzel A, Groszer M, et al. HIF-1-induced erythropoietin in the hypoxic retina protects against light-induced retinal degeneration. Nat Med. 2002;8:718–724. B. Bocker-Meffert S, Rosenstiel P, Rohl C, et al. Erythropoietin and VEGF promote neural outgrowth from retinal explants in postnatal rats. Invest Ophthalmol Vis Sci. 2002;43:2021–26. C. Junk AK, Mammis A, Savitz SI, et al. Erythropoietin administration protects retinal neurons from acute ischemia-reperfusion injury. Proc Natl Acad Sci U S A. 2002;99:10659–64.
Becerra SP, Amaral J. Erythropoietin—an endogenous retinal survival factor. N Engl J Med. 2002;347:1968–1970.
References
Transmissible Diseases and Blood Transfusion. Smit Sibinga CTh and Dodd RY, eds. Kluwer Acad. Publ. Dordrecht/Boston/London 2002:160 (discussion).
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Springer
About this chapter
Cite this chapter
(2005). Discussion. In: Smit Sibinga, C.T., Luban, N. (eds) Neonatology and Blood Transfusion. Developments in Hematology and Immunology, vol 39. Springer, Boston, MA. https://doi.org/10.1007/978-0-387-23600-1_20
Download citation
DOI: https://doi.org/10.1007/978-0-387-23600-1_20
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-387-23599-8
Online ISBN: 978-0-387-23600-1
eBook Packages: MedicineMedicine (R0)